PARP1 and Parkinson disease: The link between PARP1 and E3 ligase activity, the affected pathology in PD, and underlying circadian processes all ultimately point to a highly interrelated mechanism, implying the possibilities of circadian treatment as a preventative and treatable measure for PD.